These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38101834)

  • 21. Implementing Global Fund programs: a survey of opinions and experiences of the Principal Recipients across 69 countries.
    Wafula F; Marwa C; McCoy D
    Global Health; 2014 Mar; 10():15. PubMed ID: 24661793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversy embroils selection of new Global Fund head.
    Zarocostas J
    Lancet; 2017 Mar; 389(10072):e3. PubMed ID: 28258756
    [No Abstract]   [Full Text] [Related]  

  • 23. Reaching vulnerable populations: lessons from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Greenall M; Kunii O; Thomson K; Bangert R; Nathan O
    Bull World Health Organ; 2017 Feb; 95(2):159-161. PubMed ID: 28250520
    [No Abstract]   [Full Text] [Related]  

  • 24. Procurement Practice of Program Drugs and Its Challenges at the Ethiopian Pharmaceuticals Supply Agency: A Mixed Methods Study.
    Boche B; Mulugeta T; Gudeta T
    Inquiry; 2022; 59():469580221078514. PubMed ID: 35316108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Global Fund: replenishment and redefinition in 2010.
    Lancet; 2010 Mar; 375(9718):865. PubMed ID: 20226967
    [No Abstract]   [Full Text] [Related]  

  • 26. Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.
    Komatsu R; Korenromp EL; Low-Beer D; Watt C; Dye C; Steketee RW; Nahlen BL; Lyerla R; Garcia-Calleja JM; Cutler J; Schwartländer B
    BMC Infect Dis; 2010 Apr; 10():109. PubMed ID: 20433714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
    Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
    Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global Fund to Fight AIDS, Tuberculosis and Malaria: funding for unpopular public-health programmes.
    Kerr T; Kaplan K; Suwannawong P; Jürgens R; Wood E
    Lancet; 2004 Jul 3-9; 364(9428):11-2. PubMed ID: 15234838
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Struggling Global Fund approves grants for HIV, TB, and malaria. But board meeting is marred by warnings about shortfalls and accusations of political manoeuvering.
    Kapp C
    Lancet; 2003 Oct; 362(9393):1381. PubMed ID: 14594000
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
    Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global Fund for AIDS, TB and malaria opens shop.
    Walgate R
    Bull World Health Organ; 2002; 80(3):259. PubMed ID: 11984617
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financing to Global Fund slashed by the Bush administration.
    Nelson R
    Lancet; 2004 Feb; 363(9407):461. PubMed ID: 14964034
    [No Abstract]   [Full Text] [Related]  

  • 35. Human Rights and the Global Fund to Fight AIDS, Tuberculosis and Malaria: How Does a Large Funder of Basic Health Services Meet the Challenge of Rights-Based Programs?
    Jürgens R; Csete J; Lim H; Timberlake S; Smith M
    Health Hum Rights; 2017 Dec; 19(2):183-195. PubMed ID: 29302175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of stock-outs of first line anti-tuberculosis drugs: the case of public health facilities of Addis Ababa city administration health bureau, Addis Ababa, Ethiopia.
    Sintayehu K; Zeleke ED; Temesgen B; Kifle M; Assefa DG; Zenebe K; Kassahun A; Yimer BT
    BMC Health Serv Res; 2022 Aug; 22(1):1047. PubMed ID: 35978406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Global Fund under Peter Sands.
    The Lancet
    Lancet; 2018 Mar; 391(10124):912. PubMed ID: 29536843
    [No Abstract]   [Full Text] [Related]  

  • 39. Governance and Health Aid from the Global Fund: Effects Beyond Fighting Disease.
    Kavanagh MM; Chen L
    Ann Glob Health; 2019 May; 85(1):. PubMed ID: 31099506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fuelling the Global Fund.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2019 Feb; 19(2):113. PubMed ID: 30722994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.